Cases & Deals

  • Home
  • Practices
  • Symphony Technology Group acquires divisions of United BioSource Corporation

Share

Symphony Technology Group acquires divisions of United BioSource Corporation

July 2013

Client(s) Symphony Technology Group LLC

Jones Day advised Symphony Technology Group LLC, a technology and services-focused private equity firm, in connection with its acquisition of the health economics, health outcomes, market access and retrospective epidemiology and data analytics divisions of United BioSource Corporation, a wholly owned subsidiary of Express Scripts Holding Company. Jones Day acted as special Texas legal counsel.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.